197 related articles for article (PubMed ID: 2411150)
1. Effect of proglumide on rat pancreatic growth.
Yamaguchi T; Tabata K; Johnson LR
Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
Shiratori K; Watanabe S; Shimizu K; Moriyoshi Y; Chang JH; Takeuchi T
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850
[TBL] [Abstract][Full Text] [Related]
3. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
6. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of pancreatic growth induced by pancreatico-biliary diversion in the rat. Inhibition by proglumide, benzotript, and ranitidine.
Miazza BM; Turberg Y; Guillaume P; Hahne W; Chayvialle JA; Loizeau E
Scand J Gastroenterol Suppl; 1985; 112():75-83. PubMed ID: 2409583
[TBL] [Abstract][Full Text] [Related]
8. The effect of CR 1409, a potent CCK receptor antagonist, on basal and stimulated pancreatic secretion in rat.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1990; 5(1):60-4. PubMed ID: 2293712
[TBL] [Abstract][Full Text] [Related]
9. Proglumide inhibition of trophic action of pentagastrin.
Johnson LR; Guthrie PD
Am J Physiol; 1984 Jan; 246(1 Pt 1):G62-6. PubMed ID: 6320664
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
Varga G; Papp M; Scarpignato C
Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo effect of proglumide on cholecystokinin-stimulated amylase release in mouse pancreatic acini.
Iwamoto Y; Nakamura R; Akanuma Y
Gastroenterol Jpn; 1984 Feb; 19(1):53-8. PubMed ID: 6202584
[TBL] [Abstract][Full Text] [Related]
12. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
Iwamoto Y; Yamamoto R; Kuzuya T
Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
[TBL] [Abstract][Full Text] [Related]
13. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
Katsuura G; Hsiao S; Itoh S
Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of CR-1409, a competitive inhibitor of cholecystokinin, on pancreatic exocrine secretion in the conscious rat.
Miyasaka K; Nakamura R; Funakoshi A; Kitani K
Tohoku J Exp Med; 1988 Jun; 155(2):165-72. PubMed ID: 3212779
[TBL] [Abstract][Full Text] [Related]
15. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
[TBL] [Abstract][Full Text] [Related]
17. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
Scarpignato C; Varga G; Dobronyi I; Papp M
Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
[TBL] [Abstract][Full Text] [Related]
18. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues.
Niederau C; Niederau M; Williams JA; Grendell JH
Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321
[TBL] [Abstract][Full Text] [Related]
19. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Niederau C; Liddle RA; Williams JA; Grendell JH
Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
